The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration (FDA). In a Friday press release, the agency announced its approval of the first ...

The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.

You can reach Adam on Signal at stataf.54. The Food and Drug Administration approved on Friday the first blood test for diagnosing Alzheimer’s disease, opening up a quicker way for patients to ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Two missing words tipped off Heidi Long that her mother might have dementia. Nearly a decade ago, in ...

Their large-scale analysis of United States health insurance data revealed that patients taking these medications had up to a 13% lower risk of Alzheimer’s disease each year. Based on these ...

friends and partners to create a special Mother’s Day for those living with Alzheimer’s disease or a related dementia. According to the Alzheimer’s Foundation of America, people should use ...

Here's why belly fat is more common as we age, and 3 ways to prevent it Warriors' Steph Curry puts a twist on his 'night night' celebration A judge used Trump’s own words to expose his real agenda ...

Reviewed By Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila ...

South Carolina families wondering if a loved one has Alzheimer's disease or other dementias might soon have access to a blood test that could give them some answers. A statewide consortium is also ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function. Researchers at the University ...